271 related articles for article (PubMed ID: 21483740)
1. Identification of common differentially expressed genes in urinary bladder cancer.
Zaravinos A; Lambrou GI; Boulalas I; Delakas D; Spandidos DA
PLoS One; 2011 Apr; 6(4):e18135. PubMed ID: 21483740
[TBL] [Abstract][Full Text] [Related]
2. Spotlight on differentially expressed genes in urinary bladder cancer.
Zaravinos A; Lambrou GI; Volanis D; Delakas D; Spandidos DA
PLoS One; 2011 Apr; 6(4):e18255. PubMed ID: 21483670
[TBL] [Abstract][Full Text] [Related]
3. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.
Kawakami K; Enokida H; Tachiwada T; Gotanda T; Tsuneyoshi K; Kubo H; Nishiyama K; Takiguchi M; Nakagawa M; Seki N
Oncol Rep; 2006 Sep; 16(3):521-31. PubMed ID: 16865252
[TBL] [Abstract][Full Text] [Related]
4. Identifying the mRNAs associated with Bladder cancer recurrence.
Cao H; Cheng L; Yu J; Zhang Z; Luo Z; Chen D
Cancer Biomark; 2020; 28(4):429-437. PubMed ID: 32390597
[TBL] [Abstract][Full Text] [Related]
5. DNA microarray expression profiling of bladder cancer allows identification of noninvasive diagnostic markers.
Mengual L; Burset M; Ars E; Lozano JJ; Villavicencio H; Ribal MJ; Alcaraz A
J Urol; 2009 Aug; 182(2):741-8. PubMed ID: 19539325
[TBL] [Abstract][Full Text] [Related]
6. Identification of gene expression patterns in superficial and invasive human bladder cancer.
Thykjaer T; Workman C; Kruhøffer M; Demtröder K; Wolf H; Andersen LD; Frederiksen CM; Knudsen S; Orntoft TF
Cancer Res; 2001 Mar; 61(6):2492-9. PubMed ID: 11289120
[TBL] [Abstract][Full Text] [Related]
7. Bladder cancer outcome and subtype classification by gene expression.
Blaveri E; Simko JP; Korkola JE; Brewer JL; Baehner F; Mehta K; Devries S; Koppie T; Pejavar S; Carroll P; Waldman FM
Clin Cancer Res; 2005 Jun; 11(11):4044-55. PubMed ID: 15930339
[TBL] [Abstract][Full Text] [Related]
8. Molecular Progression Risk Score for Prediction of Muscle Invasion in Primary T1 High-Grade Bladder Cancer.
Kang HW; Seo SP; Byun YJ; Piao XM; Kim YH; Jeong P; Ha YS; Kim WT; Kim YJ; Lee SC; Moon SK; Choi YH; Yun SJ; Kim WJ
Clin Genitourin Cancer; 2018 Aug; 16(4):274-280. PubMed ID: 29571585
[TBL] [Abstract][Full Text] [Related]
9. Gene discovery in bladder cancer progression using cDNA microarrays.
Sanchez-Carbayo M; Socci ND; Lozano JJ; Li W; Charytonowicz E; Belbin TJ; Prystowsky MB; Ortiz AR; Childs G; Cordon-Cardo C
Am J Pathol; 2003 Aug; 163(2):505-16. PubMed ID: 12875971
[TBL] [Abstract][Full Text] [Related]
10. Microarray-based analysis of whole-genome DNA methylation profiling in early detection of breast cancer.
Li SY; Wu HC; Mai HF; Zhen JX; Li GS; Chen SJ
J Cell Biochem; 2019 Jan; 120(1):658-670. PubMed ID: 30203578
[TBL] [Abstract][Full Text] [Related]
11. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R
Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes.
Sanchez-Carbayo M; Socci ND; Charytonowicz E; Lu M; Prystowsky M; Childs G; Cordon-Cardo C
Cancer Res; 2002 Dec; 62(23):6973-80. PubMed ID: 12460915
[TBL] [Abstract][Full Text] [Related]
13. Molecular and Bioinformatics Analyses Identify 7 Circular RNAs Involved in Regulation of Oncogenic Transformation and Cell Proliferation in Human Bladder Cancer.
Cai D; Liu Z; Kong G
Med Sci Monit; 2018 Mar; 24():1654-1661. PubMed ID: 29558461
[TBL] [Abstract][Full Text] [Related]
14. Screening of differentially expressed genes related to bladder cancer and functional analysis with DNA microarray.
Huang YD; Shan W; Zeng L; Wu Y
Asian Pac J Cancer Prev; 2013; 14(8):4553-7. PubMed ID: 24083701
[TBL] [Abstract][Full Text] [Related]
15. Arrow plot: a new graphical tool for selecting up and down regulated genes and genes differentially expressed on sample subgroups.
Silva-Fortes C; Amaral Turkman MA; Sousa L
BMC Bioinformatics; 2012 Jun; 13():147. PubMed ID: 22734592
[TBL] [Abstract][Full Text] [Related]
16. Bladder cancer stage and outcome by array-based comparative genomic hybridization.
Blaveri E; Brewer JL; Roydasgupta R; Fridlyand J; DeVries S; Koppie T; Pejavar S; Mehta K; Carroll P; Simko JP; Waldman FM
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7012-22. PubMed ID: 16203795
[TBL] [Abstract][Full Text] [Related]
17. Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A.
Lee SJ; Lee EJ; Kim SK; Jeong P; Cho YH; Yun SJ; Kim S; Kim GY; Choi YH; Cha EJ; Kim WJ; Moon SK
PLoS One; 2012; 7(9):e40267. PubMed ID: 22962576
[TBL] [Abstract][Full Text] [Related]
18. Novel robust biomarkers for human bladder cancer based on activation of intracellular signaling pathways.
Lezhnina K; Kovalchuk O; Zhavoronkov AA; Korzinkin MB; Zabolotneva AA; Shegay PV; Sokov DG; Gaifullin NM; Rusakov IG; Aliper AM; Roumiantsev SA; Alekseev BY; Borisov NM; Buzdin AA
Oncotarget; 2014 Oct; 5(19):9022-32. PubMed ID: 25296972
[TBL] [Abstract][Full Text] [Related]
19. Identifying distinct classes of bladder carcinoma using microarrays.
Dyrskjøt L; Thykjaer T; Kruhøffer M; Jensen JL; Marcussen N; Hamilton-Dutoit S; Wolf H; Orntoft TF
Nat Genet; 2003 Jan; 33(1):90-6. PubMed ID: 12469123
[TBL] [Abstract][Full Text] [Related]
20. Applications of array technology: identification of molecular targets in bladder cancer.
Sánchez-Carbayo M; Cordon-Cardo C
Br J Cancer; 2003 Dec; 89(12):2172-7. PubMed ID: 14676790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
